PFIZi028-A

B212c7

iPSC line

At European Collection of Authenticated Cell Cultures (ECACC)
Timepoint: 48hr post thaw
Magnification: x4
Timepoint: 48hr post thaw
Magnification: x10
Timepoint: Confluency
Magnification: x4
Timepoint: Confluency
Magnification: x10
A CLIP contains information about a cell line including any specific third party obligations relating to, for example, licensing obligations or the donor consent which affect the use of the cell line.
A batch specific Certificate of Analysis will be available to download once you receive your EBiSC iPSC line.

General#

Cell Line

hPSCreg Name PFIZi028-A
Alternative name(s)
B212c7
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
UKKi017-A
(NP0075-8D)
Donor diseases:
Hypertrophic cardiomyopathy
UKKi018-A
(NP0080-2B)
Donor's gene variants:
KCNH2
Donor diseases:
Familial long QT syndrome
UKKi019-A
(NP0081-1A)
Donor's gene variants:
KCNH2
Donor diseases:
Familial long QT syndrome
UKKi025-A
(NP0135-1)
Donor's gene variants:
MYH7
Donor diseases:
Hypertrophic cardiomyopathy
UKKi018-B
(NP0080-6A)
Donor's gene variants:
KCNH2
Donor diseases:
Familial long QT syndrome
UKKi019-B
(NP0081-11)
Donor's gene variants:
KCNH2
Donor diseases:
Familial long QT syndrome
UKKi019-C
(NP0081-12C)
Donor's gene variants:
KCNH2
Donor diseases:
Familial long QT syndrome
UKKi017-B
(NP0075-10K)
Donor diseases:
Hypertrophic cardiomyopathy
UKKi017-C
(NP0075-11B)
Donor diseases:
Hypertrophic cardiomyopathy
UKKi025-B
(NP0135-2)
Donor's gene variants:
MYH7
Donor diseases:
Hypertrophic cardiomyopathy
UKKi025-C
(NP0135-7)
Donor's gene variants:
MYH7
Donor diseases:
Hypertrophic cardiomyopathy
UKKi018-C
(NP0080-8B)
Donor's gene variants:
KCNH2
Donor diseases:
Familial long QT syndrome
UKKi027-A
(NP0101-A, NP0101-3D)
UKKi027-C
(NP0101-C, NP0101-10H)
UKKi028-A
(NP0115-A, NP0115-4)
UKKi028-B
(NP0115-B)
UKKi028-C
(NP0115-C)
UKKi036-A
(NP0143-A, NP0143-5)
UKBi011-A
(iLB-AD-169bm-s24)
Donor's gene variants:
APOE, APOE
Donor diseases:
Alzheimer disease
UKKi026-C
(NP0114-5E)
UKKi035-B
(NP0139-B, NP0139-6C)
Donor's gene variants:
MYBPC3, MYBPC3
Donor diseases:
Hypertrophic cardiomyopathy
UKKi037-C
(NP0144-C, NP0144-41)
UKKi016-A
(NP0078-10)
Donor's gene variants:
KCNQ1
Donor diseases:
Familial long QT syndrome
UKKi023-A
(NP0126-1)
Donor's gene variants:
KCNH2
Donor diseases:
Familial long QT syndrome
UKKi024-A
(NP0133-5)
Donor diseases:
Brugada syndrome
UKKi026-A
(NP0114-1A)
UKKi023-B
(NP0126-5)
Donor's gene variants:
KCNH2
Donor diseases:
Familial long QT syndrome
UKKi023-C
(NP0126-6)
Donor's gene variants:
KCNH2
Donor diseases:
Familial long QT syndrome
UKKi024-B
(NP0133-1)
Donor diseases:
Brugada syndrome
UKKi024-C
(NP0133-4)
Donor diseases:
Brugada syndrome
UKKi006-A
(D4-cB, M4C4, NP0053-5)
UKKi007-A
(NP0014-6, UKK007Ai)
Donor's gene variants:
RYR2, RYR2
Donor diseases:
Catecholaminergic polymorphic ventricular tachycardia
UKKi009-B
(NP0011-19)
Donor's gene variants:
KCNH2
Donor diseases:
Prolonged QT interval
UKKi007-B
(NP0014-5)
Donor's gene variants:
RYR2
Donor diseases:
Catecholaminergic polymorphic ventricular tachycardia
UNEWi001-A
(UNEW001Ai)
Donor's gene variants:
PRPF31
Donor diseases:
Retinitis pigmentosa
UNEWi002-A
(UNEW002Ai, PRPF31 AW)
Donor's gene variants:
PRPF31, PRPF31
Donor diseases:
Retinitis pigmentosa
RCi004-A
(PDSC-10, RCi150)
Donor's gene variants:
HTT, HTT
Donor diseases:
Huntington disease
RCi004-B
(RCi68, PDSC-3)
Donor's gene variants:
HTT, HTT
Donor diseases:
Huntington disease
UKBi005-A
(iLB-C-31f-r1, LB-31-1)
UKBi007-A
(LB-33-5, iLB-MJD3-33f-r5)
Donor's gene variants:
ATXN3, ATXN3
Donor diseases:
Spinocerebellar ataxia type 3
EDi001-A
(AST22, AST23, SAMEA3319992)
Donor's gene variants:
SNCA, SNCA, SNCA
Donor diseases:
Parkinson disease
EDi002-A
(NAS2)
WTSIi003-A
(HPSI1213i-hehd_2)
WTSIi005-A
(HPSI1113i-podx_1)

Provider

Depositor Pfizer Limited - Pfizer (PFIZ)
Distributors
EBiSC
European Collection of Authenticated Cell Cultures (ECACC)

External Databases

hPSCreg PFIZi028-A
BioSamples SAMEA104491452
ECACC 66540639
Cellosaurus CVCL_VE76
CLO CLO_0101713
Wikidata Q54947282

General Information

* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: allowed
Commercial use: allowed

Donor Information#

General Donor Information

Sex female
Age of donor (at collection) 5-9

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
Neurodevelopmental Disorder
The donor is a carrier of a disease-associated mutation and affected.
Synonyms
  • Neurodevelopmental Disorder
Genetic variants
C12orf57 (target)
12p13.31
NM_138425.3:c.184C>T
SCV000490446.1
p.Gln62Stop (CAG>TAG): c.184 C>T in exon 2 in the C12orf57 gene (NM _138425.3)
DHPS (target)
19p13.13
NM_001930.4:c.518A>G
NP_001921.1:p.Asn173Ser
DHPS (target)
19p13.13
NM_001930.4:c.1014+1G>A

External Databases (Donor)

BioSamples SAMEA104491451

hIPSC Derivation#

General

Source cell type
peripheral blood mononuclear cell
A leukocyte with a single non-segmented nucleus in the mature form found in the circulatory pool of blood.
Age of donor (at collection) 5-9

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Genes
Is reprogramming vector detectable?
No
Methods used
RT-PCR

Vector free reprogramming

Other

Derived under xeno-free conditions
No
Derived under GMP?
No
Available as clinical grade?
No

Culture Conditions#

Latest released batch

Culture medium mTeSR™1
Passage method EDTA
Surface coating matrigel / Geltrex
O2 concentration 21
CO2 concentration 5
Temperature 37
The following are the depositor culture conditions, they do not refer to any specific batch.
Surface coating Matrigel/Geltrex
Passage method Enzyme-free cell dissociation
EDTA
O2 Concentration 20 %
CO2 Concentration 5 %
Medium mTeSR™ 1
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
No

Characterisation#

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR FACS Enzymatic Assay Expression Profiles
POU5F1 (OCT-4)
Yes
TRA 1-60
Yes
SSEA-4
Yes
SSEA-1
No
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro directed differentiation
Marker Expressed
SOX17
Yes
GATA6
Yes
CXCR4
Yes
Mesoderm
Ont Id: UBERON_0000926
In vitro directed differentiation
Marker Expressed
Vimentin
Yes
NCAM
Yes
MIXL1
Yes
Ectoderm
Ont Id: UBERON_0000924
In vitro directed differentiation
Marker Expressed
PAX6
Yes
NeuroD1
Yes
HES5
Yes

Microbiology / Virus Screening

HIV 1 Negative
HIV 2 Negative
Hepatitis B Negative
Hepatitis C Negative
Mycoplasma Negative

Sterility

Inoculation for microbiological growth No Contaminants Detected
Mycoplasma Not Detected
Viability Viable post-cryopreservation

Genotyping#

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46, XX; Modal karyotype in 20 cells showed a normal female chromosome complement and banding pattern
Passage number: 12
Karyotyping method: G-Banding

Other Genotyping (Cell Line)